阿尔茨海默病的精准诊断与治疗.pptVIP

AD的神经病理 New Brain Imaging FDA Approves Amyvid for Clinical Use April 9, 2012, The Food and Drug Administration (FDA) has approved Amyvid (florbetapir F18 injection), Avid Pharmaceuticals/Eli Lilly October 25, 2013 ，The US Food and Drug Administration (FDA) today announced approved of flutemetamol F18 injection (Vizamyl, GE Healthcare), a radioactive diagnostic tracer for use with positron emission tomography (PET) of the brain in adults being evaluated for Alzheimers disease (AD) and dementia Biomarker model of the preclinical stage of AD 改变病程进展的药物研究 改变病程进展的药物研究 病人选择的变化（MCI、无症状） 主要疗效指标的变化